Hayden Royal’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$154K Sell
664
-779
-54% -$171K 0.36% 98
2021
Q3
$279K Sell
1,443
-3
-0.2% -$608 0.46% 59
2021
Q2
$308K Buy
1,446
+142
+11% +$30K 0.17% 140
2021
Q1
$266K Buy
1,304
+187
+17% +$36.8K 0.15% 146
2020
Q4
$206K Buy
+1,117
New +$190K 0.11% 199
2020
Q2
Sell
-2,108
Closed -$365K 182
2020
Q1
$365K Buy
2,108
+457
+28% +$91K 0.21% 119
2019
Q4
$352K Buy
+1,651
New +$339K 0.18% 135
2019
Q3
Sell
-1,079
Closed -$223K 167
2019
Q2
$223K Buy
+1,079
New +$199K 0.24% 129
2019
Q1
Sell
-1,113
Closed -$209K 136
2018
Q4
$209K Buy
+1,113
New +$206K 0.11% 178

Other funds holding CME

Hayden Royal's CME Position: Q4 2021 in Review

Hayden Royal reduced its CME Group (CME) stake by 54% in Q4 2021, selling an estimated $171K and leaving 664 shares worth $154K. The position accounts for 0.36% of the portfolio, ranked #98.

Hayden Royal first reported a position in CME in Q4 2018 and has held it in 9 quarters since. The position peaked at $365K in Q1 2020. 1,147 funds tracked by Wall St. Rank hold CME as of Q4 2021.

  • Hayden Royal held 664 shares of CME Group worth $154K as of Q4 2021.
  • Hayden Royal sold 779 CME Group shares in Q4 2021, an estimated $171K.
  • CME Group made up 0.36% of Hayden Royal's portfolio in Q4 2021, its #98 holding.
  • Hayden Royal first reported a position in CME Group in Q4 2018 and has held it in 9 quarters since.
  • Hayden Royal's CME Group position peaked at $365K in Q1 2020.
  • 1,147 funds tracked by Wall St. Rank held CME Group as of Q4 2021.

Based on Hayden Royal's 13F filing for Q4 2021, filed 7 Feb 2022.